{"url_path":"/sec/plyx/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/2075320/0001213900-26-056973-index.html","accession_number":"0001213900-26-056973","cik":"0002075320","ticker":"PLYX","issuer_name":"Polaryx Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2075320/0001213900-26-056973-index.html","primary_entity_key":"0002075320","primary_entity_name":"Polaryx Therapeutics, Inc."},"word_count":77,"has_tables":true,"body_markdown":"Item 1. Legal Proceedings.\n\n \n\nWe are not party to any material legal proceedings\nat this time. From time to time, we may become involved in various legal proceedings that arise in the ordinary course of our business.\nRegardless of outcome, litigation can have an adverse impact on us due to defense and settlement costs, diversion of management resources,\nnegative publicity, reputational harm and other factors, and there can be no assurances that favorable outcomes will be obtained."}